AHA: FTC approach to reviewing hospital transactions seriously flawed

The Federal Trade Commission’s approach to reviewing hospital mergers “is overbroad, does not properly credit the many pro-consumer benefits of hospital transactions, and ignores key realities of the marketplace,” according to an analysis submitted to the agency for a series of FTC hearings on Competition and Consumer Protection in the 21st Century. Performed for the AHA by Charles River Associates in conjunction with antitrust counsel at Wilson Sonsini Goodrich & Rosati, the analysis describes “serious flaws” in the supply and demand models that the FTC uses to evaluate the competitive effects of hospital transactions.

Related Resources

Webinar Recordings
This webinar is presented by: Sarah E. Wakeman, MD Medical Director, Massachusetts General Hospital Substance Use Disorder Initiative Medical Director,…
AHA comments on the Department of Health and Human Services’ proposed rule to set expiration dates for its regulations (subject to certain exceptions), unless…
For decades, the AHA's Ameriplan Report served as a blueprint for a number of proposals on national health insurance and health care reform.
AHA Center for Health Innovation Market Scan
Leaders need to think strategically about the pandemic’s impact on health care in the near and long term and plan for a future defined by resilience and…
Other Resources
About Project TRANSFORM Prisma health-Upstate, University of South Carolina School of Medicine-Greenville and Clemson University School of Nursing have…
Member Non-Fed
This is a downloadable Model Letter to Submit Comments to CMS on Proposed Rule on Stark Law that the AHA has created for your use.